Package Leaflet: Information for the Patient
Sycrest 5mg sublingual tablets
Sycrest 10mg sublingual tablets
asenapine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Sycrest contains the active substance asenapine. This medicine belongs to a group of medicines called antipsychotics. Sycrest is used to treat moderate to severe manic episodes associated with bipolar I disorder in adults. Antipsychotic medicines affect the chemicals in the brain that enable communication between brain cells (neurotransmitters). Brain diseases, such as bipolar I disorder, may be due to an imbalance of certain brain chemicals, such as dopamine and serotonin, and these imbalances can cause some of the symptoms you are experiencing. It is not known exactly how this medicine works, but it is thought to adjust the balance of these chemicals.
Manic episodes associated with bipolar I disorder are an illness with symptoms such as feeling well, having excessive energy, needing to sleep much less than usual, talking very quickly with many ideas, and sometimes great irritability.
Do not take Sycrest
If you are allergic to asenapine or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before you start taking Sycrest.
Sycrest has not been studied in elderly patients with dementia. However, these patients who are being treated with other types of similar medicines may have a higher risk of stroke or death. Sycrest has not been approved for the treatment of elderly patients with dementia and is not recommended for use in this particular group of patients.
Sycrest may cause a drop in blood pressure. In the early stages of treatment, some people may faint, especially when standing up after lying down or sitting. It usually goes away on its own, but if it does not, tell your doctor, as you may need a dose adjustment.
Asenapine may cause drowsiness, sudden drops in blood pressure when standing up, dizziness, and changes in your ability to move and balance, which can lead to falls and, consequently, fractures or other traumatic injuries. Patients at risk of falls should be assessed before asenapine is prescribed.
Tell your doctor immediately if you experience
Before taking Sycrest, check with your doctor or pharmacist:
You should be aware that both diseases can be caused by this type of medicine.
Make sure to tell your doctor if you are in any of these circumstances so that he/she can adjust your dose or monitor you for some time. Also, consult your doctor immediately if you develop any of these conditions or if they worsen while you are using Sycrest.
Children and adolescents
The use of Sycrest is not recommended in patients under 18 years of age.
Other medicines and Sycrest
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Some medicines may reduce or increase the effect of Sycrest.
If you are taking other medicines, Sycrest should be taken last.
You should tell your doctor if you are taking antidepressant medicines (specifically fluvoxamine, paroxetine, or fluoxetine), as it may be necessary to change your dose of Sycrest or your dose of antidepressant.
You should tell your doctor if you are taking medicines for Parkinson's disease (such as levodopa), as this medicine may make them less effective.
Sycrest acts mainly in the brain, so there may be interference with other medicines (or with alcohol) that also act in the brain due to a sum of effects on brain function.
Sycrest may decrease blood pressure, so caution should be exercised when Sycrest is taken with other medicines that decrease blood pressure.
Taking Sycrest with food, drinks, and alcohol
Do not eat or drink for 10 minutes after taking this medicine.
You should avoid drinking alcohol when taking this medicine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take Sycrest while you are pregnant, unless your doctor tells you to. If you are taking this medicine and become pregnant or plan to become pregnant, consult your doctor as soon as possible to find out if you can continue taking Sycrest.
The following symptoms may occur in newborn babies of mothers who have been treated with Sycrest in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
Do not breastfeed while you are taking Sycrest.
Driving and using machines
Sycrest may cause drowsiness or sedation. Therefore, make sure your concentration and alertness are not affected before driving or using machines.
Follow exactly the instructions of administration of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is one 5 or 10 mg sublingual tablet twice a day. One dose should be taken in the morning and another dose should be taken at night.
Instructions for use
Sycrest is for sublingual use.
Sycrest is not recommended if you are not able to take the tablet as described below. If you are not able to take this medicine as described below, the treatment may not be effective for you.
Figure 1 Figure 2 Figure 3
If you take more Sycrest than you should
If you take too much Sycrest, contact a doctor immediately. Bring the medicine with you. In case of overdose, you may feel drowsy or tired, have abnormal body movements, problems standing or walking, feel dizzy due to a drop in blood pressure, and feel agitated and confused.
If you forget to take Sycrest
Do not take a double dose to make up for forgotten doses. If you forget to take a dose, take your next dose as usual. If you forget to take two or more doses, consult your doctor or pharmacist.
If you stop taking Sycrest
If you stop taking Sycrest, you will lose the effects of this medicine. You should not stop taking this medicine unless your doctor tells you to, as your symptoms may come back.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects have been reported with this medicine. Seek medical attention immediately if you have any of the following symptoms:
Tell your doctor immediately if you have:
Other side effects reported with this medicine are:
Very common side effects(may affect more than 1 in 10 people)
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton. The expiry date is the last day of the month stated.
Store this medicine in the original package to protect it from light and moisture.
This medicine does not require any special storage temperature.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Sycrest Composition
Product Appearance and Package Contents
The 5 mg sublingual tablets are round, white to off-white, marked with "5" on one side.
The 10 mg sublingual tablets are round, white to off-white, marked with "10" on one side.
The sublingual tablets are supplied in peelable blisters, each containing 10 tablets. The packs contain 20, 60 or 100 tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder
N.V. Organon
Kloosterstraat 6
NL-5349 AB Oss
Netherlands
Manufacturer
Organon Heist bv
Industriepark 30
2220 Heist-op-den-Berg, Belgium
You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:
Belgium Organon Belgium Tel: 0080066550123 (+32 2 2418100) dpoc.benelux@organon.com | Lithuania Organon Pharma B.V. Lithuania branch Tel.: +370 52041693 dpoc.lithuania@organon.com |
Bulgaria Organon Bulgaria EOOD Tel: +359 2 806 3030 dpoc.bulgaria@organon.com | Luxembourg Organon Belgium Tel: 0080066550123 (+32 2 2418100) dpoc.benelux@organon.com |
Czech Republic Organon Czech Republic s.r.o. Tel: +420 233 010 300 dpoc.czech@organon.com | Hungary Organon Hungary Kft. Tel.: +36 1 766 1963 dpoc.hungary@organon.com |
Denmark Organon Denmark ApS Tlf: +45 4484 6800 info.denmark@organon.com | Malta Organon Pharma B.V., Cyprus branch Tel: +356 2277 8116 dpoc.cyprus@organon.com |
Germany Organon Healthcare GmbH Tel.: 0800 3384 726 (+49 (0) 89 2040022 10) dpoc.germany@organon.com | Netherlands N.V. Organon Tel: 00800 66550123 (+32 2 2418100) dpoc.benelux@organon.com |
Estonia Organon Pharma B.V. Estonian branch Tel: +372 66 61 300 dpoc.estonia@organon.com | Norway Organon Norway AS Tlf: +47 24 14 56 60 info.norway@organon.com |
Greece BIANEΞ Α.Ε. Tel: +30 210 80091 11 Mailbox@vianex.gr | Austria Organon Healthcare GmbH Tel: 0800 3384 726 (+49 (0) 89 2040022 10) dpoc.austria@organon.com |
Spain Organon Salud, S.L. Tel: +34 91 591 12 79 organon_info@organon.com | Poland Organon Polska Sp. z o.o. Tel.: +48 22 105 50 01 organonpolska@organon.com |
France Organon France Tel: +33 (0) 1 57 77 32 00 | Portugal Organon Portugal, Sociedade Unipessoal Lda. Tel: +351 218705500 geral_pt@organon.com |
Croatia Organon Pharma d.o.o. Tel: +385 1 638 4530 dpoc.croatia@organon.com | Romania Organon Biosciences S.R.L. Tel: +40 21 527 29 90 dpoc.romania@organon.com |
Ireland Organon Pharma (Ireland) Limited Tel: +353 15828260 medinfo.ROI@organon.com | Slovenia Organon Pharma B.V., Oss, Ljubljana branch Tel: +386 1 300 10 80 dpoc.slovenia@organon.com |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia Organon Slovakia s.r.o. Tel: +421 2 44 88 98 88 dpoc.slovakia@organon.com |
Italy Organon Italia S.r.l. Tel: +39 06 90259059 dpoc.italy@organon.com | Finland Organon Finland Oy Tel: +358 (0) 29 170 3520 dpoc.finland@organon.com |
Cyprus Organon Pharma B.V., Cyprus branch Tel: +357 22866730 dpoc.cyprus@organon.com | Sweden Organon Sweden AB Tel: +46 8 502 597 00 dpoc.sweden@organon.com |
Latvia Organon Pharma B.V. branch in Latvia Tel: +371 66968876 dpoc.latvia@organon.com | United Kingdom (Northern Ireland) Organon Pharma (UK) Limited Tel: +44 (0) 208 159 3593 medicalinformationuk@organon.com |
Date of the last revision of this leaflet:{month/YYYY}.
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.
The average price of SYCREST 10 mg SUBLINGUAL TABLETS in October, 2025 is around 156.32 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.